Cite
HARVARD Citation
Nissinen, T. et al. (2018). Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses. Journal of cachexia, sarcopenia and muscle. 9 (3), pp. 514-529. [Online].